Safety, Tolerability and Pharmacokinetics of Liposomal Curcumin in Healthy Volunteers - A Phase I Dose Escalation Study.

Trial Profile

Safety, Tolerability and Pharmacokinetics of Liposomal Curcumin in Healthy Volunteers - A Phase I Dose Escalation Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2014

At a glance

  • Drugs Curcumin (Primary)
  • Indications Breast cancer; Cancer; Conduction disorders; Lymphoma; Pancreatic cancer; Parkinson's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Signpath Pharma
  • Most Recent Events

    • 09 Apr 2013 Results presented at the 104th Annual Meeting of the American Association for Cancer Research.
    • 08 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top